Home » Topics » Disease categories and therapies » Substance use and poisoning

Substance use and poisoning
RSS

Signature Therapeutics receives award to advance abuse-deterrent oxycodone

Aug. 2, 2013

Invion begins phase II INV-102 trial

July 26, 2013

Novel drug and drug target for the treatment of addictive disorders characterized

July 24, 2013

Pluristem's PLX cells tested for treatment of radiation poisoning

July 17, 2013

Novel kappa receptor antagonists disclosed by Research Triangle Institute

July 1, 2013

First patient dosed in phase III study of Zubsolv for new indication

June 19, 2013

Neumedicines receives BARDA award for HemaMax

June 11, 2013

Nippon Shinyaku launches Regtect in Japan

May 27, 2013

Neumedicines receives BARDA intent to exercise contract option on HemaMax

May 17, 2013

Biotie reports initiation of NIH-funded study of nepicastat in cocaine dependence

May 13, 2013

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 23, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 23, 2026.
Cell/gene therapy sector now sustainable; China competition mounting
BioWorld
There was an upbeat message for cell and gene therapy companies in the 2026 industry update presented as the J.P. Morgan Healthcare Conference opened on Monday,...
Neurotrimin unveiled as marker in intellectual disability
BioWorld Science
Neurotrimin (NTM) is a member of the IgLON family, the disruption of which has been tied to emotional learning deficits and anxiety-like behavior in animal...
Biallelic variants in COX18 identified as cause of Charcot-Marie-Tooth disease
BioWorld Science
Charcot-Marie-Tooth (CMT) disease is a group of clinically and genetically heterogeneous sensorimotor peripheral neuropathies. It is the most frequent inherited...